Democrats on a U.S. House of Representatives panel are planning to call Valeant Pharmaceuticals (VRX.TO) Chief Executive Michael Pearson to testify in early 2016 about steep price hikes for some of the company’s drugs, a Democratic aide said. The hearing before the House Oversight Committee could be held as early as late January as part of an ongoing probe into sky rocketing drug prices, a Republican committee aide said.